Statins are associated with decreased mortality risk after status epilepticus.

TitreStatins are associated with decreased mortality risk after status epilepticus.
Publication TypeJournal Article
Year of Publication2015
AuthorsSierra-Marcos, A, Alvarez, V, Faouzi, M, Burnand, B, Rossetti, AO
JournalEuropean Journal of Neurology
Volume22
Issue2
Pagination402-405
Date Published02/2015
DOI10.1111/ene.12428
ISSN1468-1331 (Electronic)
Mots-clésAdult, Aged, Aged, 80 and over, Cohort Studies, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Male, Middle Aged, Prognosis, Status Epilepticus, Treatment Outcome
Abstract

BACKGROUND AND PURPOSE: Statins display anti-inflammatory and anti-epileptogenic properties in animal models, and may reduce the epilepsy risk in elderly humans; however, a possible modulating role on outcome in patients with status epilepticus (SE) has not been assessed.

METHODS: This cohort study was based on a prospective registry including all consecutive adults with incident SE treated in our center between April 2006 and September 2012. SE outcome was categorized at hospital discharge into 'return to baseline', 'new disability' and 'mortality'. The role of potential predictors, including statins treatment on admission, was evaluated using a multinomial logistic regression model.

RESULTS: Amongst 427 patients identified, information on statins was available in 413 (97%). Mean age was 60.9 (±17.8) years; 201 (49%) were women; 211 (51%) had a potentially fatal SE etiology; and 191 (46%) experienced generalized-convulsive or non-convulsive SE in coma. Statins (simvastatin, atorvastatin or pravastatin) were prescribed prior to admission in 76 (18%) subjects, mostly elderly. Whilst 208 (50.4%) patients returned to baseline, 58 (14%) died. After adjustment for established SE outcome predictors (age, etiology, SE severity score), statins correlated significantly with lower mortality (relative risk ratio 0.38, P = 0.046).

CONCLUSION: This study suggests for the first time that exposure to statins before an SE episode is related to its outcome, involving a possible anti-epileptogenic role. Other studies are needed to confirm this intriguing finding.

Notes

Publication types: Journal Article Publication Status: ppublish

Alternate URL

http://www.ncbi.nlm.nih.gov/pubmed/24684345?dopt=Abstract

First publication date (online)

03/2014

WOS ID (UT)

000347701300028

Alternate JournalEur. J. Neurol.
Citation Key / SERVAL ID5782
Peer reviewRefereed
PubMed ID24684345

                         

IUMSP | www.iumsp.ch
Institut universitaire de médecine sociale et préventive
Route de la Corniche 10, 1010 Lausanne - Switzerland
+41 21 314 72 72 | dess.info@unisante.ch

Go to top